Literature DB >> 2784191

An immunodeficiency characterized by defective signal transduction in T lymphocytes.

T Chatila1, R Wong, M Young, R Miller, C Terhorst, R S Geha.   

Abstract

We studied a nine-year-old boy with severe, recurrent infections. The patient was exposed in utero to azathioprine and prednisone. He had autoimmune hemolytic anemia, bronchiectasis, and Hodgkin's disease. The patient's circulating lymphocytes were normal in number and phenotype, but stimulation of the T-cell receptor by antigens, mitogens, and monoclonal antibodies failed to induce interleukin-2-receptor expression, interleukin-2 synthesis, or lymphocyte proliferation. The early biochemical events necessary to initiate lymphocyte activation--accumulation of the second messenger diacylglycerol, activation of the enzyme protein kinase C, and elevation of the free intracellular calcium concentration--failed to occur in this patient's lymphocytes. The defect in the lymphocyte could be corrected in vitro by two agents that bypass the receptor-mediated signal mechanism (the diacylglycerol analogue phorbol and the calcium ionophore ionomycin). Further studies localized the defect in signal transduction to the interaction between cell-surface receptors and the guanine nucleotide-binding protein. We conclude that this patient's immunodeficiency was caused by a defective coupling of surface receptors to signal-transducing proteins in his T lymphocytes, resulting in failure of lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784191     DOI: 10.1056/NEJM198903163201104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  16 in total

1.  A hereditary immunodeficiency characterized by CD8+ T lymphocyte deficiency and impaired lymphocyte activation.

Authors:  W J Monafo; S H Polmar; S Neudorf; A Mather; A H Filipovich
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

Review 2.  Structure and function of the T cell antigen receptor.

Authors:  A Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

3.  Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes.

Authors:  T Chatila; E Castigli; R Pahwa; S Pahwa; N Chirmule; N Oyaizu; R A Good; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 4.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  Failure of T cell receptor-anti-CD3 monoclonal antibody interaction in T cells from marrow recipients to induce increases in intracellular ionized calcium.

Authors:  M Yamagami; P W McFadden; S M Koethe; V Ratanatharathorn; L G Lum
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Cloning and expression of the human vasoactive intestinal peptide receptor.

Authors:  S P Sreedharan; A Robichon; K E Peterson; E J Goetzl
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  DNA polymorphism in cytokine genes based on length variation in simple-sequence tandem repeats.

Authors:  C O Jacob; K Mykytyn; N Tashman
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

8.  Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients.

Authors:  L Manzano; M Alvarez-Mon; J A Vargas; J A Girón; L Abreu; A Fernández-Corugedo; L I Román; F Albarran; A Durántez
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

9.  Dissociation between phytohaemagglutinin-stimulated generation of inositol phosphates and Ca2+ increase in human mononuclear leucocytes.

Authors:  M C Michel; L J van Tits; G Trenn; J Sykora; O E Brodde
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

10.  Regulation of interleukin 3 gene induction in normal human T cells.

Authors:  S C Guba; G Stella; L A Turka; C H June; C B Thompson; S G Emerson
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.